Medical corruption is shocking.
April 22, 2015, Hangzhou Iron and Steel Group Company Staff Hospital former director Chen was sentenced to eight years in prison and confiscation of 80,000 yuan of property in the first trial according to the law, because of his behavior constitutes the crime of accepting bribes. (hereinafter referred to as "Hengrui Pharmaceuticals") and a number of other well-known pharmaceutical companies, businessman bribery also came to light.
The China Business News reporter noted that Hengrui's salesmen have been involved in many cases of bribery of hospital staff. However, each time the incident broke out, the companies involved seem to be able to "retreat", and did not prevent it from continuing to soar in the market.
Multiple times involved in the case
Hengrui Medicine is the largest research and production base of antitumor drugs and surgical drugs, one of the country's most innovative large-scale pharmaceutical companies in the industry has always been to focus on the image of innovation.
The financial report shows that in 2014, the company's main revenue of 7.452 billion yuan, an increase of 20.14% year-on-year; to achieve net profit of 1.516 billion yuan, an increase of 22.41% year-on-year. In contrast, marketing expenses in 2014 amounted to 2.58 billion yuan, accounting for 34.6% of the year's operating income.
And the high market expenses or provide a convenient door for businessmen to pay bribes.
Hangzhou City, Zhejiang Province, Gongshu District People's Court criminal judgment shows that between 2010 and 2014, Hengrui Medicine Hangzhou area salesman Song in order to and Hangzhou Iron and Steel Group Company Staff Hospital former director Chen Mou good relations, and to thank for its help in the sale of medicines such as clarithromycin into Hangzhou steel hospitals, successively and repeatedly in the name of the defendant Chen Mou **** counted The defendant Chen *** counted RMB 20,000 yuan.
Song's testimony proved that his Hengrui Medicine and Hanggang Hospital has Nuobang (Clarithromycin), Beilei (Ambroxol Oral Liquid), Lega (Sodium, Potassium, Magnesium and Calcium Injection), Virette (Dexamethasone), Ruifi and other medicines business, and at the end of 2009, Song took over the business of Hanggang Hospital. Lega and Virette was its handling into Hangang Hospital, also let Chen Mou help. The New Year festivals, Song gave Hanggang Hospital Chen *** counting 20,000 yuan in cash. 2010 or 2011, Chen said to go to Hainan or Xiamen to play, let Song share a little. Song Mou remembered as if Chen Mou took the travel invoice to be reimbursed by Song Mou. Songmou in front of Chenmou's neighborhood or Hangzhou Second Middle School, will be 10,000 yuan in cash to Chenmou.
In fact, this is not the first time in recent years that a Hengrui Medicine salesman has been involved in a medical corruption case.
In June 2014, Suzhou Intermediate People's Court in Jiangsu Province, a criminal verdict showed that the defendant Chen Mou used his position as director and vice president of the First People's Hospital in Wujiang City, accepting Hengrui Pharmaceutical Group Co., Ltd.'s Suzhou office director Zhang Mou entrusted to seek benefits for him on pharmaceutical procurement matters, and for the above reasons, has twice in his Wujiang First People's Hospital office illegally Received RMB 16,000 yuan from Zhang.
In April 2014, the criminal judgment of Fugu County People's Court of Shaanxi Province showed that: during the period of 2008 to 2013, during the promotion of drugs to Yulin No. 2 Hospital by Jiangsu Hengrui Pharmaceutical Co., Ltd. businessman Wang Mou, in order to enable his drugs to enter the sales of No. 2 Hospital smoothly, and at the same time to keep the drugs he was already selling not to be removed, he paid bribes of RMB 635,000 to the director of the pharmacy department of Yulin No. 2 Hospital, Liu Mou. 6.35 million yuan.
Wang's testimony showed that he began working as a salesman for Jiangsu Hengrui Pharmaceuticals Co. in 2005, and in 2006, he began to sell medicines mainly in the second hospital in Yulin. Because the second hospital in Yulin City, additional drugs into the drug directory must be agreed through Liu Weibin, so he sent 10,000 yuan on October 14, 2008 to Liu Weibin, January 13, 2009 to Liu Weibin sent 10,000 yuan, September 22, 2009 to Liu Weibin sent 10,000 yuan. In addition, in February 2012, he paid Liu Weibin 18,500 yuan for travel expenses and gave Liu Weibin 0.5 million yuan to thank him for his care in the process of marketing drugs.
What is Hengrui Medicine's explanation for the involvement of its salesmen in the above cases? Has it taken relevant corrective measures in this regard? Hengrui Medicine replied to the newspaper that the company has no knowledge of the above, and is doing further understanding and verification of the situation.
It is worth noting that these businessmen involved in the cases appeared in the judgment as witnesses, without being noted as being dealt with in a separate case.
In fact, as early as June 30, 2008, the Henan Provincial Department of Health named 36 pharmaceutical companies that paid bribes to hospitals and doctors in Henan Province, and Hengrui Medicine was listed, and at that time the variety involved was oxaliplatin.
August 22, 2012, a signed as "Hengrui medicine former medical representative" of the net post suddenly appeared on the network, the article said "disclosure of Hengrui medicine's unlawful behavior", mainly disclosed the Hengrui medicine in the first hospital attached to Guangxi Medical University, Guangxi Cancer Hospital, etc., the main disclosure of Hengrui medicine in the first hospital, Guangxi Cancer Hospital. The main disclosure of Hengrui Medicine in Guangxi Medical University Affiliated Hospital, Guangxi Cancer Hospital and other hospitals to carry out the business process, suspected of paying a high amount of medical kickbacks to doctors.
The network disclosure of the document said, Aisin, oxaliplatin, calcium folinate, cisatracurium and other more than 20 products are suspected of bribery, the first hospital attached to the Guangxi Medical University Radiotherapy, chemotherapy, gynecology, cardiothoracic surgery, gastrointestinal adenosonectomy, and other sections of the Department of a number of doctors appeared in the list of "involved in the bribery".
The company's then securities affairs representative Xu Guowen in an interview with a media reporter firmly denied that Hengrui Medicine is suspected of bribery, completely false, and said that has been through the judicial process to resolve this slander, but the matter ultimately ended up unsettled.
And all this has not been a hindrance to Hengrui Medicine to continue to soar in the market.
The financial report shows that in the first quarter of 2015, the company's operating income of 2.204 billion yuan, an increase of 28.03%, net profit of 547 million yuan, an increase of 40.2%.
The May 27 closing, Hengrui medicine shares rose 5.19%, the total market value of 101.2 billion yuan, to become the first to enter the 100 billion yuan of market value of the club of listed companies in the pharmaceutical industry.
Subterranean rules are difficult to break
Pharmaceutical business personnel to the hospital staff bribes into the industry's "unspoken rules", a number of pharmaceutical companies, business personnel also in the case of Hangzhou Steel has played a dishonorable role.
Hangzhou Gongshu District Court judgment also shows that from 2005 to 2014, Zhejiang Haiwang Pharmaceutical Co., Ltd. deputy general manager of Jin Mou in order to thank the defendant Chen Mou in its agent of the drugs in the introduction of new drugs, stopping the reuse of medicines, drugs, the amount of help given to the defendant Chen Mou*** counted value of 86,000 yuan in the second half of 2012, the defendant Chen Mou ** counted the value of the property. Zhejiang kangenbei medicine sales co., ltd, zhejiang district manager huang mou for and defendant chen mou good relations so that can get in the drug sales care, in defendant chen mou's office to give him cash RMB3000.
The bribe-taker went to jail, and the bribe-giver could not be held criminally liable because of minor circumstances. So the drug companies that gained benefits from it can also "get away with it"?
In fact, the relevant state departments have long established a medical purchase and sale of commercial bribery in the field of "blacklist" system, pharmaceutical companies once the implementation of commercial bribery was found to be included in the bad record, affecting the bidding of its products.
According to the National Health and Planning Commission, "on the establishment of medicine purchase and sale of commercial bribery in the field of bad record provisions", drugs, medical equipment and medical supplies production, business enterprises or their agents and individuals to give the procurement and use of its drugs, medical equipment and medical supplies to the staff of health institutions to the property or other benefits, one of the following circumstances should be included in the bad record of commercial bribery: By the people's court judgment that constitutes the crime of bribery, or the crime is minor and does not require a sentence, the people's court in accordance with the criminal law sentenced to be exempted from criminal penalties; bribery crime is minor, the people's procuratorate to make a decision on non-prosecution.